Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users

Perceptual and Motor Skills

Volumn 104, Issue 1, 2007, Pages 43-55

  Groth Marnat, Gary ^a   Howchar, Hennedy ^b   Marsh, Ali ^b  

^a Pacifica Graduate Institute   (United States)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE;

ADOLESCENT; ADULT; ARTICLE; COCAINE DEPENDENCE; COMPARATIVE STUDY; DRUG ABUSE; DRUG EFFECT; FEMALE; HUMAN; MALE; MEMORY; PSYCHOLOGICAL ASPECT; WECHSLER INTELLIGENCE SCALE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE WITHDRAWAL SYNDROME; WECHSLER SCALES;

EID: 34247544299     PISSN: 00315125     EISSN: None     Source Type: Journal    
DOI: 10.2466/PMS.104.1.43-55     Document Type: Article

References (39)

1. ABBOTT, A., & CONCAR, D. (1992) A trip into the unknown. New Scientist, August 29, 30-34.
2. AGUIRRE, N., GALBETE, J. L., LASHERAS, B., & DEL RIO, J. (1995) Methylenedioxymethamphetamine induces opposite changes in central pre- postsynaptic 5-HTIA receptors in rats. European Journal of Pharmacology, 281, 101-105.
3. BOLLA, K. I., MCCANN, U. D., & RICAURTE, G. A. (1998) Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology, 51, 1532-1537.
4. BUHOT, M-C., MARTIN, S., & SEGU, L. (2000) Role of serotonin in memory impairment. Annals of Medicine, 32, 210-221.
5. CROFT, R. J., MACKAY, A. J., MILLS, A. T. D., & GRUZELIER, J. G. (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373-379.
6. CURRAN, H. V., & TRAVILL, R. A. (1997) Mood and cognitive effects of ± 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction, 92, 821-831.
7. DAFTERS, R. I., DUFFY, F., O'DONNELL, P. J., & BOUQUET, C. (1999) Level of use of 3,4- methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEC power and coherence. Psychopharmacology, 145, 82-90.
8. DARKE, S., WARD, J., HALL, W., HEATHER, N., &WODAK, A. (1991) The Opiate Treatment Index (OTI), manual. New South Wales, Austral.: National Drug and Alcohol Research Centre.
9. GOSSOP, M., DARKE, S., GRIFFITHS, P., HANDO, J., POWIS, B., HALL, W., & STRANG, J. (1995) The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. London: Society for the Study of Addiction to Alcohol and Other Drugs.
10. HATZIDIMITRIOU, G., MCCANN, U. D., & RICAURTE, G. A. (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with 3,4-methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. Journal of Neuroscience, 19, 5096-5107.
11. KLUGMAN, A., HARDY, S., BALDEWEG, T., & GRUZELIER, J. (1999) Toxic effect of MDMA on brain serotonin neurons. Lancet, 353, 1269-1271.
12. MCCANN, U. D., MERTL, M., E LIGULASHVILI, V., MURPHY, D. L., & RICAURTE, G. A. (1999) Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. Psychopharmacology, 147, 56-65.
13. MCKENNA, D. J., & PEROUTKA, S. J. (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Journal of Neurochemistry, 54, 14-22.
14. MCKETIN, R., & MATTICK, R. P. (1997) Attention and memory in illicit amphetamine users. Drug and Alcohol Dependence, 48, 235-242.
15. MORGAN, M. J. (1998) Recreational use of "Ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 252-264.
16. MORGAN, M. J. (1999) Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology, 141, 30-36.
17. MORGAN, M. J. (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology, 152, 230-248.
18. NELSON, H. E. (1982) National Adult Reading Test (NART), test manual. Berkshire, UK: NFER-Nelson.
19. PARROTT, A. C. (2000) Human research on MDMA (3,4-methylenedioxymethamphetamine, Neuropsychobiology, 42, 17-24.
20. PARROTT, A. C. (2001) Human psychopharmacology of ecstasy: a review of 15 years of empirical research. Human Psychopharmacology, 16, 557-577.
21. PARROTT, A. C., LEES, A., GARNHAM, N. J., JONES, M., & WESNES, K. (1998) Cognitive performance in recreational users of MDMA or "ecstasy": evidence for memory deficits. Journal of Psychopharmacology, 12, 79-83.
22. PEROUTKA, S. J. (1990) Ecstasy: the clinical, pharmacological and neurotoxicological effects of the drug MDMA. Boston, MA: Kluwer.
23. RENEMAN, L., BOOIJ, J., SCHMAND, B., VAN DER BRINK, W., & GUNNING, B. (2000) Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology, 148, 322-324.
24. RICAURTE, G. A., MARTELLO, A. L., KATZ, J. L., & MARTELLO, M. B. (1992) Lasting effects of (±)-3,4- Methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. The Journal of Pharmacology and Experimental Therapeutics, 261, 616-622.
25. RODGERS, J. (2000) Cognitive performance amongst recreational users of "ecstasy." Psychopharmacology, 151, 19-24.
26. RUDNEY, C., MACKAY, A. J., MILLS, A. T. D., & GRUZELIER, J. G. H. (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373-379.
27. SABOL, K. E., LEW, R., RICHARDS, J. B., VOSMER, G. L., SEIDEN, L. S. (1996) Methylenedioxymethamphetamine-induced serotonin deficits arc followed by partial recovery over a 52-week period: Part 1. Synaptosomal uptake and tissue concentrations. The Journal of Pharmacology and Experimental Therapeutics, 276, 846-854.
28. SCHIFANO, F., DI FURIA, L., FORZA, G., MINICUCI, N., & BRICOLO, R. (1998) MDMA ("ecstasy") consumption in the context of polydrug abuse: a report of 150 patients. Drug & Alcohol Dependence, 52, 85-90.
29. SEMPLE, D. M., EBMEIER, K. P., GLABUS, M. F., O'CARROLL, R. E., & JOHNSTONE, E. C. (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. British Journal of Psychiatry, 175, 63-69.
30. SOLOWIJ, N., HALL, W., & LEE, N. (1992) Recreational MDMA use in Sydney: a profile of 'Ecstasy' users and their experiences with the drug. British Journal of Addiction, 87, 1161-1172
31. TABACHNICK, B. G., & FIDELL, L. S. (1996) Using multivariate statistics. (3rd ed.) New York: HarperCollins College Publ.
32. TAFFE, M. A., WEED, M. R., DAVIS, S., HUITRON-RESENDIZ, S., SCHROEDER, R., PARSONS, L. H., HENRIKSEN, S. J., & GOLD, L. H. (2001) Functional consequences of repeated 3,4-Methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neuropsychopharmacology, 24, 230-239.
33. TOPP, L., HANDO, J., DILLON, P., ROCHE, A., & SOLOWIJ, N. (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug and Alcohol Dependence, 55, 105-115.
34. TURNER, J. J. D., GODOLPHIN, M., & PARROTT, A. C. (1999) Cognitive task performance profiles of current and former "Ecstasy" (MDMA) users. Journal of Psyckopharmacology, 13, 24.
35. TURNER, J. J. D., JUBY, K., & PARROTT, A. C. (1998) Spatial and object recognition performance of regular MDMA users assessed in virtual reality. Journal of Psychopharmacology, 12, 43.
36. VERKES, R. J., GIJSMAN, H. J., PIETERS, M., SCHOEMAKER, R. C., DE VISSER, S., KUIJPERS, M., PENNINGS, E. J. M., DE BRUIN, D., VAN DE WIJNGAART, G., VAN GERVEN, J. M., & COHEN, A. F. (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology, 153, 196-202.
37. WAREING, M., FISK, I. E., & MURPHY, P. N. (2000) Working memory deficits in current and previous users of MDMA (ecstasy). British Journal of Psychology, 91, 181-188.
38. WECHSLER, D. (1997) Wechsler Memory Scale - Third Edition. San Antonio, TX: The Psychological Corp.
39. ZAKZANIS, K. K., & YOUNG, D. A. (2001) Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation. Neurology, 56, 966-969.